Immunization with the attenuated plasmidless Chlamydia trachomatis L2(25667R) strain provides partial protection in a murine model of female genitourinary tract infection
- 10 February 2010
- Vol. 28 (6) , 1454-1462
- https://doi.org/10.1016/j.vaccine.2009.11.073
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Chlamydia trachomatis Native Major Outer Membrane Protein Induces Partial Protection in Nonhuman Primates: Implication for a Trachoma Transmission-Blocking VaccineThe Journal of Immunology, 2009
- TheChlamydia trachomatisPlasmid Is a Transcriptional Regulator of Chromosomal Genes and a Virulence FactorInfection and Immunity, 2008
- Structural and Functional Analyses of the Major Outer Membrane Protein ofChlamydia trachomatisJournal of Bacteriology, 2007
- Differential CD28 and Inducible Costimulatory Molecule Signaling Requirements for Protective CD4+T-Cell-Mediated Immunity against Genital TractChlamydia trachomatisInfectionInfection and Immunity, 2007
- Intranasal Vaccination with a Secreted Chlamydial Protein Enhances Resolution of GenitalChlamydia muridarumInfection, Protects against Oviduct Pathology, and Is Highly Dependent upon Endogenous Gamma Interferon ProductionInfection and Immunity, 2007
- Vaccination with theChlamydia trachomatisMajor Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live BacteriaInfection and Immunity, 2005
- Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccineNature Reviews Immunology, 2005
- Priming withChlamydia trachomatisMajor Outer Membrane Protein (MOMP) DNA followed by MOMP ISCOM Boosting Enhances Protection and Is Associated with Increased Immunoglobulin A and Th1 Cellular Immune ResponsesInfection and Immunity, 2000
- Recall of Original Serologic Response after Challenge with Homologous and Heterologous Chlamydia trachomatis SerovarsThe Journal of Infectious Diseases, 1996
- Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infectionVaccine, 1995